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Volume I: Technical Assessment Report 
1.0 Notification and Authorization  
Dr. Michael Duncan of the Johnson Space Center (JSC) Space and Life Sciences Directorate 
(SLSD) requested NASA Engineering and Safety Center (NESC) support for an independent 
peer review of the In-Suit Light Exercise (ISLE) Prebreathe Protocol for use prior to 
extravehicular activity (EVA) on the International Space Station (ISS).   
NESC Director Ralph Roe approved an NESC out-of-board activity on August 11, 2010.  Mr. 
Tim Brady, JSC, was selected as the assessment lead.  An initial summary for this assessment 
was presented at the August 12, 2010, NESC Review Board (NRB) meeting.  The NRB 
approved the assessment plan on September 16, 2010. 
The ISLE peer review convened on October 14, 2010, to examine the physiological, modeling, 
and operations data related to the ISLE Prebreathe Protocol and assess the decompression 
sickness (DCS) risk regarding the use of the protocol.  Following the presentation of data, a 
Review Committee conducted 4 hours of deliberations on October 14, 2010, and later continued 
the deliberations between the voting Committee members through email.  
The Review Committee produced a final report (see Appendix C) which was submitted to Dr. 
James Polk of JSC SLSD and Mr. Brady on November 9, 2010.  This NESC report integrates the 
Review Committee’s final report with additional background material.  
The key stakeholders for this assessment are Dr. Polk and Mr. Derek Hassmann of the JSC Flight 
Directors Office. 
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2.0 Signature Page 
 
 
Submitted by:  
 
Team Signature Page on File – 2/22/11 
 
 
Mr. Timothy K. Brady  Date  Dr. James D. Polk    Date  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Signatories declare the findings and observations compiled in the report are factually based from 
data extracted from Program/Project documents, contractor reports, and open literature, and/or 
generated from independently conducted tests, analysis, and inspections. 
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3.0 List of Team Members, Ex Officio Members, and Others 
Name Discipline Organization 
ISLE Prebreathe Protocol Peer Review Committee (Non-voting) 
J.D. Polk Chief, Space Medicine Division, 
SLSD 
JSC 
Tim Brady NESC Lead NESC SEO  
Pat Forrester NESC Astronaut Representative Astronaut Office 
Nigel Packham Safety and Mission Assurance JSC  
ISLE Prebreathe Protocol Peer Review Committee (Voting) 
Caroline Fife Consultant The University of Texas Health 
Science Center at Houston  
Bruce Butler Consultant The University of Texas Health 
Science Center at Houston 
Ralph Frankowski Professor of Biostatistics The University of Texas School of 
Public Health  
Richard Jennings Consultant The University of Texas Medical 
Branch  
Richard Moon Consultant Duke University Medical Center  
Paul Sheffield Consultant International ATMO, Inc.  
Keith Van Meter Consultant Keith Van Meter and Associates   
Presenters 
Derek Hassmann Flight Director JSC 
Joe Dervay Lead EVA Flight Surgeon, Medical 
Operations 
JSC 
Mike Gernhardt Astronaut Office JSC 
Megan Murphey EVA Operations Branch JSC 
Johnny Conkin Biomedical Research and 
Operations Branch 
JSC 
Alan Feiveson Biomedical Research and 
Operations Branch 
JSC 
Administrative Support 
Pam Throckmorton MTSO Program Analyst LaRC 
Melinda Meredith Project Coordinator LaRC/ATK 
Carolyn Snare Technical Writer LaRC/ATK 
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4.0 Executive Summary 
The atmospheric pressure of the International Space Station (ISS) is 14.7 pounds per square inch 
(psi), or sea level, whereas the pressure inside the suits used for extravehicular activity (EVA) is 
4.3 psi.  Thus the performance of EVA by National Aeronautics and Space Administration 
(NASA) astronauts involves the risk of decompression sickness (DCS).  This risk has been 
mitigated by the use of oxygen (O2) ―prebreathe‖ to effectively wash out tissue nitrogen (N2) 
prior to each EVA.  The family of prebreathe protocols developed for the demanding EVA 
schedule of ISS construction has performed well.  None of the 331 EVAs conducted from the 
Space Shuttle Orbiter and the ISS reported DCS.  
Now that the Space Shuttle Program (SSP) is being retired, high-pressure oxygen will become a 
limited resource.  The In-Suit Light Exercise (ISLE) Prebreathe Protocol offers several potential 
benefits including its potential to save 6 pounds (lb) of oxygen per EVA, and that it does not 
require astronaut isolation in the air lock overnight as does the ―Campout‖ Prebreathe Protocol.  
In ground-based testing of ISLE, the measured incidence of DCS was 4.3%, which met the 
accept criteria at the 95% confidence interval (CI).  Although the Grade IV venous gas emboli 
(VGE) incidence of 16.7% was within the accept criterion of ≤ 20%, the upper confidence limit 
(CL) failed to meet the 95% CI.  In addition, questions existed as to whether the ―light exercise‖ 
requirement could be validated by perceived exertion or necessitated confirmation by the O2 
sensor in the extravehicular mobility unit (EMU).  
At the request of the NESC, the peer review convened on October 14, 2010.  The major 
recommendation of the Review Committee was that the ISLE protocol was acceptable for 
operational use as a prebreathe option prior to EVA.  Furthermore, since the necessary O2 
consumption rate of 6.8 ml·kg
-1
·min
-1 
is marginally above a resting rate and is virtually 
guaranteed by the nature of normal pre-EVA tasks, the use of the EMU suit O2 sensor is not 
necessary to determine whether an adequate metabolic rate has been achieved.  However, the 
collection of O2 sensor readings may be useful for research. 
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5.0 Assessment Plan 
The JSC SLSD requested NESC support for a peer review of the ISLE Prebreathe Protocol prior 
to EVA for use on the ISS.  The ISLE Protocol involves in-suit light exercise during a 1.5-hour 
prebreathe period.  The ISLE Protocol was developed based on the protocol tested on the ground 
in the Phase V-5 series of the Prebreathe Reduction Program (PRP).  Ground trials of the Phase 
V-5 Protocol are complete and the peer review was requested to review the ISLE Protocol in 
addition to the multi-level board approval process prior to use on orbit.  The Committee 
reviewed the physiological, modeling, test subject data, and operations associated with this 
Protocol and risk associated with DCS.   
A peer review panel was originally formed under NESC Request 05-032-E (05-00137) in May 
2005 to review the Campout Protocol prior to its use on ISS.  A majority of the medical expert 
panelists from the 2005 review participated in this activity.  For the ISLE Prebreathe Protocol 
assessment, a representative from the JSC Safety and Mission Assurance (S&MA) organization 
and the NESC astronaut representative were added to the Review Committee. 
6.0 Report and Appendices Overview  
The appendices to this NESC final report provide background material related to the ISLE 
Prebreathe Protocol and include presentations made during the October 14, 2010, ISLE 
Prebreathe Protocol peer review.  See Volume II for the appendices. 
7.0 ISLE Prebreathe Protocol Peer Review Team Consultation 
Plan 
The assessment plan established the ISLE Prebreathe Protocol Review within the NESC.  It 
defined the mission, responsibilities, membership, and conduct of operations for this assessment.  
This assessment was initiated out of board by NESC Director Ralph Roe.  NESC’s mission is to 
perform value-added independent testing, analysis, and assessments of NASA projects to ensure 
safety and mission success.  The objective of this assessment was to review the physiological, 
modeling, and operations data related to DCS risk regarding the use of the ISLE Prebreathe 
Protocol.  Specific questions were posed to the Review Committee in the Charge to the 
Committee (See Section 8.0), with the findings and recommendations to be documented in a 
written report and outbriefed to the NRB and identified stakeholders. 
The ISLE Prebreathe Protocol Review Committee presentation activities on October 14, 2010, 
were led by Mr. Tim Brady.  Dr. Caroline Fife from the University of Texas Health Science 
Center, Houston, was tasked with assembling the independent voting members of the 
Committee.  Members of JSC SLSD and the EVA operations community identified the critical 
areas of information necessary for the Committee briefing.  Informational materials were 
circulated to the voting and non-voting members prior to the meeting date.  Presentations were 
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made during the meeting at the Center for Advanced Space Studies in Houston, Texas, to 
educate the Review Committee about the background of ISLE Prebreathe Protocol development, 
physiology of altitude DCS, statistical methods for development and analysis, modeling data, 
and aspects of operations which were pertinent to this review (e.g., available equipment, physical 
limitations, etc.).  Results from the Phase V-5 ground test were extensively reviewed.  The Phase 
V-5
1
 ground test protocol was representative of the ISLE Prebreathe Protocol which would be 
operationally implemented on ISS.   
Presenters included Mr. Derek Hassmann who presented the Flight Director operations 
perspective, Dr. Joe Dervay who presented EVA prebreathe protocol history, Dr. Mike 
Gernhardt who presented the research summary, Ms. Megan Murphey who presented the 
operational prebreathe timelines, Dr. Johnny Conkin and Dr. Al Feiveson who together presented 
modeling methods, and Mr. Tim Brady who presented the Charge to the Review Committee.   
After the Charge was presented by Mr. Brady, the Committee was allowed to deliberate privately 
with the input of the non-voting members under the supervision of Mr. Brady, Dr. Nigel 
Packham, and Col. Pat Forrester, NESC Chief Astronaut.  The EVA Integrated Product Team 
(IPT) presenters remained available during Committee deliberations to answer questions. 
Analysis Techniques Used 
The Review Committee consisted of seven voting members (Dr. Fife, Dr. Richard Jennings, Dr. 
Bruce Butler, Dr. Ralph Frankowski, Dr. Paul Sheffield, Dr. Richard Moon, and Dr. Keith Van 
Meter) and four non-voting members (Mr. Brady, Dr. Polk, Dr. Packham, and Col. Forrester).  
The Review Committee deliberated for approximately 4 hours.  The Committee requested Dr. 
Frankowski to estimate the number of subjects which would have been necessary to reach the 
95% CI for the Phase V-5 accept/reject criteria.  Dr. Gernhardt answered questions posed by the 
Committee via telephone during their deliberations.  Deliberations continued after the meeting 
through email.  Key statements were crafted by the members and emailed to the voting members 
who voted by email using a ―Delphi‖ approach.  Draft statements were revised until there was 
unanimous agreement by the voting members.  A draft report prepared by Dr. Fife was circulated 
by email for review.  Dr. Polk and Mr. Brady reviewed the report with regard to the accuracy of 
the background information and the NESC procedural details.  The Committee’s final report was 
submitted to Dr. Polk and Mr. Brady on November 9, 2010.  The ISLE Prebreathe Protocol Peer 
Review final report was presented to the NRB for approval on December 14, 2010.  
                                                 
1
 Phase V-5 refers to the ISLE ground prebreathe protocol test in the PRP discussed in Section 9.4. 
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8.0 The Charge to the ISLE Prebreathe Protocol Peer Review 
Committee  
 Is the ISS ISLE Prebreathe Protocol acceptable for operational use with the O2 tank 
pressure transducer readings as guidance for controlling the crew metabolic rate during 
the light exercise period? 
 Is the ISS ISLE Prebreathe Protocol acceptable for operational use using ratings of 
perceived exertion (RPE) of 7 or greater as a control to insure adequate metabolic rate 
has been achieved during the light exercise period? 
 What, if any, additional controls would be recommended for implementation of the ISLE 
Prebreathe Protocol for routine operational use on ISS? 
9.0 ISLE Prebreathe Protocol Background and the Statement of 
the Problem 
9.1 Background of Prebreathe Testing 
The testing of prebreathe protocols has evolved since the 1970s.  A variety of methods has been 
used including ground-based testing of specific prebreathe protocols with the later addition of 
―adynamia‖ (no ambulation) simulations, mathematical modeling based on accumulated data 
from closely related studies, and multi-center prospective trials to evaluate specific prebreathe 
techniques.  NASA’s goal is not the performance of DCS research.  The primary goal is the 
development of safe and effective DCS countermeasures for EVA.  A secondary goal is a better 
understanding of prebreathe mechanisms.  Thus, these prospective trials have been designed with 
operational considerations in mind and with carefully defined a priori accept/reject criteria. 
Early prebreathe protocol development focused only on delivering acceptable/effective counter 
measures.  Later development focused on increased efficiency and improved scientific 
understanding of countermeasure mechanisms.  The evolution of the overarching goals of 
prebreathe research is reflected in the changing design of the trials.  Early in the SSP, Dr. James 
Waligora tested many prebreathe protocols (3, 3.5, and 4 hours) in which the DCS incidence 
ranged from 20–36%.  Exercise simulated the arm movement of the crank on the Space Shuttle 
Orbiter payload doors and other Orbiter contingency tasks.  In testing the 4-hour ―In-suit‖ 
Prebreathe Protocol and the 1-hour, 10.2 psi ―staged decompression,‖ specific ―R‖ values were 
identified for acceptable tissue tensions, and ―reject‖ criteria were identified (e.g., ―Grade 3 
DCS, any Type II, pain limiting performance, etc.‖).  In the 10.2-psi staged decompression 
prebreathe ground-based tests, a DCS incidence of 23% was observed.  
In the late 1990s, the EVA requirements for ISS necessitated prebreathe protocols which were 
more time and operationally efficient.  Research that enabled the PRP to proceed included the 
recognition that ground-based microgravity simulation was an important experimental variable 
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and the discovery that exercise significantly enhances N2 off-gassing (e.g., 10 minutes of 
exercise at 75% O2 intake (VO2) peak during a 1-hour prebreathe protocol was equivalent to a 4-
hour resting O2 prebreathe).  The goal was to reduce the prebreathe time by 50% over the 4-hour 
protocol while maintaining or increasing the safety margins to DCS and to certify this protocol in 
time for the installation of the ISS joint airlock.  A 2-hour exercise prebreathe protocol for ISS 
was developed by 1999.  During that period, the EVA culture was transformed to a ―diving 
environment‖ mentality with a clear DCS treatment and disposition policy which did not 
penalize astronauts for reporting DCS should it occur.  Improved on-orbit treatment protocols 
were developed which allowed in-suit recompression breathing O2 (4.3–8 psi over ambient). 
Over the years, four prebreathe protocols have been developed which allow flexibility similar to 
that used in diving.  These protocols have had extensive use during EVAs on the Space Shuttle 
Orbiter and on ISS.   
 3.5 hour In-Suit Prebreathe; 4.0 hour In-Suit Prebreathe 
 10.2 psi Staged Prebreathe 
 2-hour Cycle Ergometer with Vibration Isolation and Stabilization (CEVIS) Exercise 
Protocol 
 ISS Airlock Campout Prebreathe Protocol 
The prebreathe protocol selected for each EVA is based on operational, technological, and 
astronaut preference factors.  There has been one instance in which an unintended break in 
Campout Protocol necessitated moving to the Exercise Prebreathe Protocol.  On this occasion, 
automatic repressurization of the air lock occurred as a result of a false depressurization alarm.  
Thus, the availability of multiple prebreathe options has provided operational flexibility.  
9.2 EVA Protocol Metrics (as of 17 August 2010) 
 3.5 hour In-Suit Prebreathe 
o 2 person-EVA in one use 
 4.0 hour In-Suit Prebreathe 
o 4 person-EVAs in two uses 
 10.2 psi Staged Prebreathe 
o 151 person-EVAs in 75 uses 
 CEVIS Exercise Prebreathe 
o 38 person-EVAs in 19 uses 
 Campout Prebreathe 
o 136 person-EVAs in 68 uses 
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In 331 EVAs there have been no reported cases of DCS.  Discussions with astronauts and the 
established policy allowing return to EVA status if DCS was reported (assuming certain 
conditions are met) indicate that these statistics do not reflect a lack of reporting but indeed, the 
absence to date of recognized DCS symptoms related to EVA over the past 10 years.  Possible 
reasons for this are discussed below. 
Initially, ―acceptable risk” in ground-based prebreathe protocol development was defined by the 
following parameters: 
The highest DCS risk consistent with a 95% probability that two of three members 
would always be available for EVA was 21%, and that during testing, DCS and 
Grade IV VGE incidence would be below the threshold for any reported case of 
Type II DCS.   
Acceptable DCS risks were further reduced to account for related medical factors such as an on-
orbit treatment delay of 30–45 minutes for re-pressurization, and the presence of a patent 
foramen ovale (PFO), which might result in neurological symptoms due to arterialized venous 
gas.  To address this issue, experimental ground-based protocol design further specified that 
Type I DCS remain at a threshold below which no cases of Type II DCS have been reported in 
the literature.  In 244 tests with 7,692 exercising subjects, neurological DCS is not observed until 
the incidence of Type I DCS exceeds 15% [ref. 1].   
Thus, for the Phase V-5 ground test protocol, the accept limit was a DCS incidence ≤ 15% at 
95% CL and Grade IV VGE ≤ 20% at 95% CL.  The reject limit was a DCS incidence > 15% at 
70% CL and Grade IV VGE > 20% at 70% CL.  The protocol was also rejected if there was a 
case of DCS classified as Type II.  
It must be noted that the a priori accept/reject criteria established in testing protocols for ISS 
were far more rigid than those used for testing the SSP prebreathe protocols.  The Review 
Committee felt the accept/reject limits for the Phase V-5 ground trial were more conservative 
than any previous EVA prebreathe trial. 
9.3 Statement of the Problem 
In the Phase V-5 ground-based testing, the measured incidence of DCS with ISLE was 4.3% 
(two cases of Type I DCS in 47 trials).  The upper one-sided exact binomial CL for the true 
incidence of DCS was 12.8%.  There were no cases of Type II DCS with the Phase V-5 ground 
trial.  This met the accept criteria of ≤ 15% DCS at 95% CL.   
In ground- based testing, the measured incidence of Grade IV VGE was 16.7% (eight cases of 
Grade IV VGE in 48 trials).  The upper 95% one-sided exact binomial CL for the true incidence 
of Grade IV VGE was 28.1%.  Although the point estimate of VGE incidence of 16.7% is within 
the accept criterion of Grade IV VGE ≤ 20%, the upper CL fails to meet the 95% CL 
requirement.  The upper 64% CL for Grade IV VGE was 19.96%.  Thus, to qualify for 
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acceptance, the 95% CI requirement would have to be reduced to a 64% CI requirement.  
Alternatively, these results could be examined from a Bayesian perspective wherein a probability 
statement could be made about P(VGE) given the experimental results of eight cases in 48 trials.  
Using a (conservative) uniform prior for P(VGE), the posterior distribution of P(VGE) given the 
data is distributed as Beta (9, 41) distribution.  With this posterior distribution, the probability 
that P(VGE) exceeds 20% is about 33.2% [ref. 2].  Despite the failure of Grade IV incidence to 
meet the 95% CI requirement for acceptance, the Bioastronautics EVA-IPT unanimously agreed 
that the Phase V-5 ISLE Prebreathe Protocol should move forward for consideration for 
operational use.  
The Review Committee assessed the operational issues that are driving ISLE consideration even 
though ISLE did not meet accept criterion at the 95% CI.  For ISS-based EVA, the Campout 
Protocol has worked well but does have the logistical issue of isolation.  The ISLE Protocol has 
some advantage over the Exercise Prebreathe Protocol in that the CEVIS exercise bicycle is not 
necessary and it provides an alternative for those who find the prebreathe mask uncomfortable.  
However, high-pressure O2 will become a limited resource once resupply from the Space Shuttle 
Orbiters is no longer available.  For some years, until an engineering solution is developed and 
delivered to ISS, there will be no way to recharge the high-pressure O2 supply.  Post SSP 
retirement, support of ISS could require eight EVAs per year, although a realistic requirement is 
one to two EVAs per year (see Appendix D). 
The Review Committee felt the ISLE Prebreathe Protocol has the potential to offer several 
benefits, including: 
 Is expected to save 6 lb of O2 per EVA 
 Does not require astronaut isolation in the air lock overnight compared to the Campout 
Protocol 
 Requires less crew time on prebreathe hose mask (which can be uncomfortable and 
difficult to use) 
 Could be a better down-mode option if the Campout Protocol is broken (which has 
occurred one time to date) 
 Allows astronauts to ―get out the door‖ 13–30 minutes earlier than CEVIS Exercise 
Protocol 
 Diminishes the ―rushing‖ to prepare for campout  
 Does not require crew to either do a bathroom break on their 120-ft prebreathe hose or 
use piddle packs 
 Does not require VO2 peak testing as exercise prescription is based on weight only (6.8 
ml·kg
-1
·min
-1
) 
 Is a simpler procedure overall than CEVIS Exercise Protocol 
ISLE Prebreathe Protocol has some potential operational disadvantages and/or challenges, 
including: 
  
NASA Engineering and Safety Center  
Technical Assessment Report 
Document #: 
NESC-RP-
10-00659 
Version: 
1.0 
Title: 
Phase V-5 In-Suit Light Exercise (ISLE)  
Prebreathe Protocol 
Page #: 
16 of 
29 
 
NESC Request No.: TI-10-00659 
 Astronauts would  ―get out the door‖ about 60 minutes later than Campout Protocol 
 Requires about 100-minute in-suit prebreathe time versus 50 minutes in-suit on Campout 
Protocol 
 Presupposes a certain (minimal) level of exercise in-suit during the prebreathe (see 
Section 9.7), which could use O2-sensor readings as a general, non-required guide of 
activity 
9.4 The Development of ISLE Prebreathe Protocol 
The PRP was initiated in 1997 with the objective to develop, test, certify, and implement a 2-
hour Prebreathe Protocol for EVA in time for first use of the ISS joint airlock [ref. 4].  The PRP 
ground test study was reviewed by an external expert committee chaired by Dr. C.J. Lambersten 
and the accept/reject criteria were more conservative than any previous EVA prebreathe trial.  
The PRP study was a sequential, multi-center trial, utilizing informed consenting subjects 
representative of the astronaut population in terms of age, gender, fitness, and percentage of 
body fat. 
The mission driver was a 95% probability that two of three crew members would be available for 
EVA throughout the ISS Program, combined with additional medical/operational considerations, 
which resulted in the following accept/reject limits: 
 Accept: DCS < 15% and Grade IV VGE < 20%, at 95% CL  
 Reject: DCS > 15% or Grade IV VGE > 20%, 70% C, or any case of Type II DCS 
There was a 50-trial minimum to control type II error to less than 1%.  The research plan 
anticipated testing up to four protocol options.  Previous Phase V in-suit exercise protocols did 
not incorporate a 10.2-psi depress/repress, and PRP data (all protocols) showed that the 10.2-psi 
depress/repress significantly reduced DCS and VGE.  Thus, a 10.2-psi depress/repress was added 
to the Phase V-5 Protocol.  
Table 9.4-1 provides the PRP summary results. 
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Table 9.4-1. Summary of Results from PRP Protocol Series 
 
*Includes one case of Type II DCS 
**Based on 48 acceptable trials for Grade IV VGE and 47 trials for DCS 
 
The Phase V-5 Protocol consists of 60 minutes of O2 on mask while performing EVA 
preparations followed by a 10.2-psi depress (light exercise at 5.8 ml·kg
-1
·min
-1
) on enriched air 
(0.265% O2).  This is followed by a 30-minute suit donning at 10.2 psi, and then 50 minutes of 
in-suit light activity (6.8 ml·kg
-1
·min
-1
), which is equivalent to walking a mile in 70 minutes, 
breathing O2.  It must be noted that this degree of exercise can be achieved with minimal effort.  
There is a final 50-minute in-suit prebreathe at rest, breathing O2. 
 
 
 
 
 
 
 
 
 
Figure 9.4-1. ISLE Prebreathe Protocol Operational Timeline 
 
The measured incidence of Grade IV VGE was 16.7% (eight cases in 48 trials).  This was within 
the accept criterion of ≤ 20% Grade IV VGE but not at the 95% CL.  With the low incidence of 
DCS in the Phase V-5 Protocol, the increased incidence of Grade IV VGE could not be 
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explained based on age, gender, aerobic fitness, total O2 consumption, total prebreathe time, or 
relationships between DCS and Grade IV VGE in PRP and NASA historical results.  
It is possible that considering only Grade IV VGE and not considering the effects of lower 
grades or the persistence of decompression stress reduces the sensitivity to differences between 
protocols.  The prebreathe studies included VGE sampling in each 20-minute block of time 
(epoch) spent at suit pressure (see Appendix F).  There was no significant difference (two-sided 
Fisher exact p-value = 0.56) in the total number of epochs with Grade IV VGE for Phase V-5 
and the approved-for-flight Phase II protocols (3.5% and 4.1%, respectively).  However, Phase 
V-5 had significantly lower (two-sided Fisher exact p-value = 0.02) pooled Grade III-IV VGE 
than Phase II (6.8% versus 10.6%, respectively).  Given that combined Grade III and IV VGE 
are generally associated with statistically increased risk of DCS, it may be that a strict focus on 
Grade IV VGE only may be a less than comprehensive measure of decompression stress.  The 
duration of VGE grade at the highest grade level within an epoch is not measured, only the 
notation of maximal VGE grade. 
The laboratory protocol does not include the additional safety margin built into the flight 
protocol including extra prebreathe time during the configuration checks, leak check, purge, and 
5-psi suit over-pressurization during crewlock depress.  All of these activities add approximately 
25 minutes of O2 prebreathe that was not performed on the Phase V-5 laboratory protocol (i.e., in 
practical use, astronauts performing the ISLE Prebreathe Protocol would get more O2 prebreathe 
than subjects in Phase V-5 ground-based testing). 
9.5 Additional Analysis 
Drs. Conkin and Feiveson presented supplemental analysis of Phase V-5 data for additional 
insight into a variety of issues which might impact decision making.  These analyses are 
presented below in the form of questions (Q) and answers (A).  The additional analysis 
presupposes that the VGE data collected over 25 years is ―perfect‖ and contains no DCS 
diagnostic error, no bias in VGE grading, and that maximum VGE is adequate information. 
Q: Does accounting for the frequency of 0 VGE improve the confidence in the observations from 
V-5? 
Since the predictive value (PV) is 98% for ―no VGE‖ and PV is only 32% for ―VGE‖ in current 
NASA data, the question arose as to whether accounting for Grade 0 VGE could provide more 
confidence in the observed 4.2% DCS than is suggested by the high Grade IV incidence. 
Data were stratified on the presence or absence of symptoms, and used random effects models 
for P(S|VGE) and P(DCS|VGE, S) to represent test-test variation and estimate standard error of 
P(DCS) estimate.  The final random effects regression equation is as follows: 
P(DCS) = (0.0166*n0 + 0.188*n123 + 0.514*n4) / n 
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where no is the number of trials within a specific test that were assigned maximum VGE grade of 
Grade 0, n123 is the number of Grade I, II, or III, n4 is the number of Grade IV, and n is the total 
number of trials in a specific test.  The regression equation provides for a computed P(DCS) for a 
test given the counts of maximum VGE grades for the trials in the test.    
A. The estimated P(DCS) given maximum VGE grade and symptoms is as follows: 
 
 
 
Q: What is the likely operational effect of a Type I DCS? 
A literature analysis was presented to gather information regarding the operational impact of 
Type DCS as a function of the probability of the severity of decompression illness (DCI) which 
cannot be determined due to stop rules.  Data from 1971 in a retrospective analysis of data going 
back to 1941 converted all symptoms into a scale of 1–4 (something worse than intolerable pain 
that cleared on descent).  
A. If there was a test which gave 30% DCS, then the expectation is that there will be mild 
categories of DCI and thus a low operational impact. 
Q: What is the estimate of Type I DCS probability given the maximum VGE grades from V-5? 
A. The estimated P(DCS) for Phase V-5 is 11.2% compared to 4.2% from direct count in the 
ground-based study.  The one-sided upper 95% CL is 17.1%.  The estimated P(DCS) was 
9.1% for Phase II compared to 11.2% for V-5, which is not considered a significant 
difference. 
Q. What might be the effect of diagnostic error on the data in V-5? 
A. The computed P(DCS) accounting for diagnostic error was 4.5% compared to 4.2% from 
direct count.  Since 44/47 trials had no report of any symptoms, then there was no 
significant contribution from diagnostic error since one diagnoses DCS based on 
symptoms.  This analysis suggests that after accounting for diagnostic error, the DCS 
impact of DCS for Phase V-5 is low. 
Q: Why is the observed incidence of DCS difference from ground-based studies? 
A. Astronauts enjoy greater protection from DCS than expected after Campout Prebreathe 
Protocol, probably through additional operational prebreathe or other protective factors in 
microgravity (e.g., resolution of bubble micronuclei).  There are additional amounts of O2 
which may not be accounted for, and there is additional exercise in the suit.  
test n observed 
DCS
one-side          
95% CL*
estimated 
P(DCS)
one-side           
95% CL
V-5 47** 0.042 0.128 0.112 0.171
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A. There is a fundamental effect of microgravity on the biology of bubble formation and 
symptom development, the mechanism of which is not understood. 
9.6 Issues Relating to the Flight Rule for the ISLE Prebreathe Protocol 
Ms. Megan Murphey provided comparisons of the EVA Prebreathe Protocols and the Review 
Committee assessed the differences between the ISLE, Exercise, Campout, and 4 hour in-suit 
Prebreathe Protocols with regard to time from post sleep to start of EVA, air lock isolation, mask 
time, prebreathe time, ISS recommended crew day length, and the number of metal oxide 
(METOX) cans used. 
With regard to METOX can usage, the ISLE Prebreathe Protocol would use about the same 
number of cans, although there are operational details regarding the re-use of partially spent 
cans.  If the ISLE Protocol is approved, then it would represent another acceptable protocol that 
can go into the ―basket of tools from which to choose.‖  The decision will be based on 
operational issues such as O2 availability, CO2 canisters, time available, isolation of campout and 
other factors.  The Review Committee felt it is likely that after SSP retirement, the ISLE Protocol 
will be the preferred prebreathe protocol due to its ability to save high-pressure O2. 
9.7 Issues Relating to the O2 Tank Pressure Sensor 
Dr. Gernhardt presented data suggesting that the drop in the O2 tank sensor pressure could be 
used as a guideline to control the ISLE metabolic rate during in-suit prebreathe.  However, this 
method is complicated by the following considerations: 
 Thermal transients associated with purge and tank refill 
o Tank pressure drops during purge at 10.2 psi, and at 14.7 psi, tanks are then 
recharged and thermal cooling causes tank pressure transients.  
 As-donned suit leak rate 
o The suits typically leave Earth with leaks of 100 standard cubic centimeters per 
minute (sccm) or less, however as donned the leak rates could be as much as 999 
sccm and still pass the leak check. 
 Tank pressure sensor error and display control module (DCM) rounding error 
o The difference between any two tank pressure readings could have an error of up 
to 2.6 psi.  The DCM could have a rounding error of 0.49 psi. 
The Review Committee was provided with a detailed description of engineering work-arounds 
for these limitations.  However, subsequent discussion focused on the On Orbit Engineering 
Assessment Exercise Prescription Table for an 80-kg subject.  ISLE Prebreathe Protocol requires 
that the in-suit exercise be performed at ―light activity‖ (6.8 ml·kg-1·min-1).  This is only slightly 
more activity than ―no exertion at all.‖  The Review Committee felt data were compelling (see 
Figure 9.7-1) that it would be virtually impossible for astronauts to fail to perform this level of 
exertion, simply by remaining awake in the suit during the 50 minutes.  Thus, while the O2 
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sensor readings may be noted, they do not appear necessary, and the previously discussed issues 
with O2 sensor accuracy argued against relying on it for this purpose. 
 
 
Figure 9.7-1. All I ST-1 Data 
 
The perceived exertion scale seemed a viable and perhaps equally reliable tool for assessing O2 
prebreathe exertion.  
 
R² = 0.622
0.0
3.4
6.8
10.2
13.6
17.0
20.4
23.8
27.2
30.6
34.0
37.4
40.8
44.2
47.6
5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
V
O
2
 (
m
l/
m
in
/k
g
)
RPE
All IST-1 Data
  
NASA Engineering and Safety Center  
Technical Assessment Report 
Document #: 
NESC-RP-
10-00659 
Version: 
1.0 
Title: 
Phase V-5 In-Suit Light Exercise (ISLE)  
Prebreathe Protocol 
Page #: 
22 of 
29 
 
NESC Request No.: TI-10-00659 
Table 9.7-1. Borg Rate of Perceived Exertion 
 
 
The crew member must exercise with a rate of perceived exertion (RPE) of 7 (i.e., they are 
performing some exertion versus an RPE of 6, which is no exertion) to ensure that an adequate 
exercise intensity was achieved.  Further discussion with Dr. Gernhardt revealed that in ground-
based testing, the exercise was specifically that of the lower legs and instructing crew members 
to move their lower legs would be required.  Discussion ensued as to whether prescribing a 
certain number of leg movements was necessary, but Dr. Gernhardt did not feel that this would 
be necessary to achieve the required exertion. 
Data from the suit’s O2 tank sensor pressure drop may provide useful information and thus would 
be valuable to collect.  
10.0 Prior Safety Committee Work 
It is important to note that there was no specific ground-based testing of the Campout Prebreathe 
Protocol.  The safety of the Campout Prebreathe Protocol was assessed based on modeling data 
and information obtained from Phase IV human trials.  Phase IV of the exercise prebreathe study 
was a 2-hour prebreathe with 95 minutes of light exercise, and a 30-minute suit-donning period 
at 10.2 psia breathing 26.5 % O2.  This ground-based test of Phase IV was nearly identical to the 
day-of-EVA Campout Prebreathe Protocol, which has the same amount of O2 prebreathe and the 
same or slightly more metabolic activity during O2 prebreathe.  Phase IV trials resulted in 14% 
DCS in 57 subjects, which did not quite meet the accept criteria for ISS EVA, but this incidence 
6 No exertion at all
7 Extremely light
8
9 Very light
10
11 Light
12
13 Somewhat hard
14
15 Hard (heavy)
16
17 Very hard
18
19 Extremely hard
20 Maximal exertion
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was lower than the ground tests of the SSP 10.2-psia staged protocol.  Compared to Phase IV, the 
Campout Prebreathe Protocol had an extra hour of O2 prebreathe, and 8 hours and 40 minutes 
overnight campout at 10.2 psia.  Modeling data suggested that the Campout Protocol would be a 
safe protocol for EVA, and the Campout Protocol Safety Committee accepted Campout on this 
basis in 2005 on the argument that it was ―analytically more conservative,‖ even though there 
was no ground-based testing for validation.  The logistic regression model predicted Campout 
Protocol to have 2.8% DCS (1.2% to 5.9%, 95% CI) based on Dr. Conkin’s work.  Nevertheless, 
there have been no reports of symptoms linked to DCS in 136 person EVAs with 68 uses of the 
Campout Protocol from the ISS.  Thus, it appears that the Campout Protocol in actual EVA use 
is safer than the model predicts.  The possible physiological and operational reasons for this have 
been previously discussed.  
The modeling techniques used to assist in the development of the prebreathe protocols are well 
known in medicine and physiology, having been used to develop, for example, the cardiac risk 
score from the Framingham Study data, as well as in pharmaceutical trials, and the techniques of 
which are accepted by the Food and Drug Administration.  It is important to note that, utilizing 
modeling techniques, the risk of DCS is almost the same for all the prebreathe protocols, and the 
CIs overlap.  There is a tendency to rank the risks within ―acceptable risks‖ even when the 
differences are small.  Given the overlapping CIs, it may be impossible to detect a real difference 
in risk between the prebreathe protocols, based on modeling. 
Analysis of the 95% Bayesian CLs for the risk differences suggests that the SSP ground 
simulation overestimates the DCS risk in EVA, while ISS ground EVA simulation may provide 
an accurate prediction of DCS risk (it is possible that the risk of DCS in ISS ground-based trials 
and EVA are the same).  The higher correlation between ISS ground-based trials and predicted 
DCS risk during EVA may be due to improved ground-based trial design.  
11.0 Proposed Solutions 
11.1 Going from Evidence to Findings and Recommendations 
Since the Prebreathe Safety Committee first met in 2005, a significant focus in clinical medicine 
has been the methodology by which research data is evaluated for its relevance to clinical 
practice guidelines.  If a practice guideline working group makes a recommendation, how much 
confidence can be placed in that recommendation?  The Grading of Recommendations 
Assessment, Development, and Evaluation (GRADE) Working Group has published extensively 
on this topic [ref. 3].  Their methods focus on the development of clinical practice guidelines 
based on the results of medical research.  Thus, these GRADE methodologies are only partially 
relevant to the process of reviewing physiological experiments for the development of NASA 
operational protocols.  Clearly the process of evaluating DCS countermeasures is quite different 
than the process of evaluating practice guidelines for stroke prophylaxis.  However, the Review 
  
NASA Engineering and Safety Center  
Technical Assessment Report 
Document #: 
NESC-RP-
10-00659 
Version: 
1.0 
Title: 
Phase V-5 In-Suit Light Exercise (ISLE)  
Prebreathe Protocol 
Page #: 
24 of 
29 
 
NESC Request No.: TI-10-00659 
Committee has been asked to weigh various types of data, specifically: randomized, controlled 
trials; predictive models; and ―real world practice‖ (i.e., EVAs); and to synthesize this diverse 
information in order to make recommendations for prevention of disease (i.e., DCS).  Since there 
are some similarities, the Safety Committee has attempted to utilize some GRADE Working 
Group techniques to assist the Review Committee in weighing the data presented and establish 
the level of confidence which can be placed in the Committee’s recommendations. 
Like the GRADE Working Group, the Review Committee has used the following definitions:  
 Quality of Evidence: indicates the extent to which one can be confident that an estimate 
of effect is correct.  
 Strength of a Recommendation: indicates the extent to which one can be confident that 
adherence to the recommendation will do more good than harm. 
There are three determinants of the strength of a recommendation: 1) the balance between the 
desirable and undesirable consequences of the alternative management strategies, on the basis of 
the best estimates of those consequences, 2) the quality of the evidence, and 3) the values of the 
stakeholders.  When advantages far outweigh the disadvantages, then the strength of a 
recommendation may increase.  If the consequences of the choice are relatively unimportant, 
even strong evidence supporting a recommendation may not matter.  If the consequences are 
very important, then evidence with less strength may take on a much more prominent role      
[ref. 3]. 
11.2 Confidence Interval Calculations 
The ground-based DCS data presented for ISLE met the criteria for acceptance of this prebreathe 
protocol.  However when Grade IV VGE data were included, the data did not meet the criteria 
for acceptance at the predetermined 95% CL for VGE Grade IV incidence ≤ 20% nor did the 
data meet the criteria for rejection of Grade IV VGE > 20% at the predetermined 70% CL.  The 
lower 70% one-sided exact binomial confidence limit for the true incidence of Grade IV VGE 
was 13.3%.  Thus, the ISLE Protocol could neither be accepted nor rejected based on the 
accept/reject limits and the reported ground-based V-5 protocol data alone.  
There are two main factors that control the width of a confidence interval: 1) sample size, and 2) 
the true underlying incidence of Grade IV VGE in the study population relative to the criterion 
value of 20% incidence for accept/reject limits.  It is not possible to detect small differences in 
VGE incidence from 20% without a very large sample size.  For example, if the Grade IV VGE 
incidence is 16.7% in the study population then a sample of at least 336 subjects would be 
required to satisfy the current VGE 20% acceptance criteria.  The implication is that for VGE 
acceptance small differences between ground-based VGE incidence and the criterion value of 
20% require very large samples. 
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Sample-size requirements can also be illustrated by recasting the rejection criteria as a traditional 
test of hypothesis.  Suppose the null hypothesis is H0:Prb(Grade IV VGE) = 20% and the 
alternative hypothesis is AH: Prb(Grade IV VGE) ≥ 25%.  Then at the 5% level of significance a 
sample size of 400 would be required to detect the alternative hypothesis with power equal to 
approximately 75%.  If the alternative hypothesis is taken to be that Prb(Grade IV VGE) ≥ 30%, 
then a sample size of approximately 100 would have 75% power at the 5% level of significance.  
Small differences require large samples and large differences require relatively smaller sample 
sizes.  These examples are presented only to suggest that with the extensive amount of VGE data 
now available it may be time to reconsider the current accept/reject criteria for the incidence of 
Grade IV VGE. 
11.3 Specific Committee Recommendations  
11.3.1 Strong Recommendation Based on a Moderate Level of Evidence 
An O2 consumption of 6.8 ml·kg
-1
·min
-1
 is barely above resting and is virtually guaranteed by the 
nature of normal pre-EVA tasks.  Thus, light lower body exercise in the suit will ensure an O2 
consumption of at least 6.8 ml·kg
-1
·min
-1
 without the use of EMU suit O2 sensor measurements 
as part of the ISLE Prebreathe Protocol.  
11.3.2 Strong Recommendation Based on a Low Level of Evidence 
Even though not necessary to accurately determine whether adequate metabolic rate has been 
achieved, in-suit O2 sensor readings collected during the light exercise period may be valuable 
for future research if collected with very specific and clear-cut objectives. 
11.3.3 Strong Recommendation Based on a Moderate Level of Evidence 
The ISLE Prebreathe Protocol is acceptable for operational use as a prebreathe option prior to 
EVA.   
11.4 Additional Observations and Recommendations by the Committee 
The Review Committee recognizes that, based on its experience, Type I or ―pain only bends‖ 
goes away with simple repressurization with or without the respiration of O2.  Were it not to 
respond to repressurization it would not endanger the life of an astronaut even though it might 
affect operations.  If serious DCS were to occur during EVA, then the most probable mechanism 
would be via arterialization of VGE.  This is because appropriate O2 prebreathe would eliminate 
N2 from well-perfused tissues so that supersaturation would be highly unlikely and thus 
autochthonous bubble formation in the brain or spinal cord could not occur during EVA.  
Therefore, the rationale for including VGE in the experimental reject criteria was to protect 
against the rare, but potentially devastating problem of a serious case of DCS arising from 
arterialization of these venous bubbles.  Thus, the Review Committee deliberates with 
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seriousness the question of whether we are in fact, being asked to alter carefully crafted 
accept/reject criteria post hoc.  The following observations were made: 
 Observation: Over the past 10 years, ground-based accept/reject research criteria have 
become ever more strict even as data have accumulated demonstrating the complete 
absence of DCS reporting during EVA.  The Review Committee raises the issue as to 
whether JSC ought to revisit the accept/reject criteria of ground-based trials in light of the 
safety data from EVA.  
 Observation: Another issue relates to the possibility whether the identified protocol has 
too many failure points, adding additional and unpredictable risks.  The Exercise 
Prebreathe Protocol reportedly has 21 potential failure points and the ISLE Prebreathe 
Protocol has fewer failure points.  It is not clear how and if the greater simplicity of the 
ISLE Protocol impacts operations including lower risk of failure. 
 Observation: Phase V-4 was rejected early due to higher rates of DCS.  The Review 
Committee discussed the phenomenon of a ―cluster effect‖ of DCS which has been well 
described in statistical analyses.  Such a cluster could cause the discontinuation of what 
might turn out to be a potentially viable protocol. 
 Observation: The early discontinuation of a trial raised numerous comments regarding 
ground-based trial design requirements.  The Review Committee recognizes the 
continuous progress of the research group as it has worked to refine and improve 
methodology.  The next logical step may be to adopt a more ―pharmaceutical Phase I and 
Phase II clinical trials‖ approach in which similar numbers of subjects are enrolled in 
each protocol even if early cases of DCS occur (unless Type II DCS occurs or the reject 
criteria are clearly met).  This will enable protocols to be evaluated against each other in 
terms of relative risk.  Not only might this further refine our understanding of 
decompression physiology, but it has distinct advantages in building a more robust 
model.  
Although the explanation remains obscure, there is now a significant body of EVA data that 
supports the notion that ground-based trials overestimate the likelihood of DCS in microgravity, 
and by inference, VGE as well.  This experience was a factor in the Review Committee’s 
recommendation to proceed with operational use of the ISLE Prebreathe Protocol.  Doppler data 
in microgravity would be extremely valuable, both to confirm this hypothesis and for use in 
future predictive studies.  Thus, the Committee felt strongly that data regarding VGE on-orbit 
would be of immense value in interpreting the predictive value of future ground-based protocols. 
12.0 Alternate Viewpoints 
There were no alternate viewpoints identified during the course of this assessment by the NESC 
team or the NRB quorum. 
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13.0 Acronyms List 
AH  Alternative Hypothesis 
ATK  Alliant Techsystems, Inc. 
CEVIS  Cycle Ergometer with Vibration Isolation and Stabilization 
CI  Confidence Interval 
CL  Confidence Limit 
DCI  Decompression Illness 
DCM  Display Control Module 
DCS  Decompression Sickness 
EMU  Extravehicular Mobility Unit 
EVA  Extravehicular Activity 
GRADE Grading of Recommendations Assessment, Development, and Evaluation 
IPT  Integrated Product Team 
ISLE  In-Suit Light Exercise 
ISS  International Space Station 
JSC  Johnson Space Center 
LaRC  Langley Research Center 
METOX Metal Oxide 
MOD  Mission Operations Directorate 
MTSO  Management and Technical Support Office 
NASA  National Aeronautics and Space Administration 
NESC  NASA Engineering and Safety Center 
NRB  NESC Review Board 
PFO  Patent Foramen Ovale 
PRP  Prebreathe Reduction Program 
RPE  Rate of Perceived Exertion 
S&MA Safety and Mission Assurance 
SEO  Systems Engineering Office 
SLSD  Space and Life Sciences Directorate 
SSP  Space Shuttle Program 
VGE  Venous Gas Emboli 
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